Abstract:OBJECTIVE:Monoclonal antibody (mAb) conjugated with certain toxin to generate immunotoxin bears an important and promising effect as a new therapy for patients with hematopoietic malignancies. However, most toxic moieties conjugated with antibody proteins reported in the literature were toxic proteins which presented immunogenicity to patients capable of inducing anti-toxin antibody. Norcantharidin (NCTD) is a small molecule toxin. It does not have the immunogenicity to human body so that it bears a promising potential for development of new targeting drug. In this study, a new clone of self-made anti-CD19 mAb named ZCH-4-2E8 conjugated with NCTD was used to investigate its targeting efficacy against CD19+ lymphoid malignant Nalm-6 cells in vitro to provide the experimental data for the further development of this new targeting agent.METHODS:A monoclonal antibody named 2E8 was prepared from mouse ascites and purified by gel chromatography. The purity of the antibody protein was checked by SDS-PAGE assay. Immunotoxin 2E8-NCTD was successfully generated through conjugating CD19 mAb protein and Norcantharidin by the activated ester method. The binding activity of the immunoconjugate (2E8-NCTD) against CD19 antigens on cell surface and the expression levels of CD19 antigens on Nalm-6 and K562 cells were examined by flow cytometry. Comparisons of the inhibitory effects among PBS, purified 2E8 antibody, norcantharidin and immunotoxin 2E8-NCTD groups on cell growth of either Nalm-6 cells or K562 cells were made.RESULTS:The purity of the purified 2E8 antibody was higher than 99.00% demonstrated by SDS-PAGE assay. 2E8 antibody in the supernatant reacted with 99.34% of Nalm-6 cells, while only 0.98% of K562 cells reacted with this antibody. The newly generated immunotoxin (2E8-NCTD) had a positive rate of 99.90% on Nalm-6 cells with little reduction of binding activity. From the in vitro study, both 2E8-NCTD and norcantharidin were shown to have significant inhibitory effects on the growth of CD19+ Nalm-6 cells (P < 0.001), while the purified 2E8 antibody did not show any significant influences on the growth of Nalm-6 cells. Since no significant inhibitory effects were identified among immunotoxin 2E8-NCTD, 2E8 antibody and control groups on CD19(-) K562 cells, a significant targeting effect of the 2E8-NCTD against Nalm-6 cells was confirmed.CONCLUSIONS:The immunotoxin 2E8-NCTD was successfully synthesized by activated ester method with an excellent targeting killing effect on CD19+ Nalm-6 leukemia cells in vitro, which provides some experimental data for the further development of this new targeting agent.

Phytohemagglutinin Isolectins Extracted and Purified from Red Kidney Beans and Its Cytotoxicity on Human H9 Lymphoma Cell Line

Human Alpha Galactosidase and Alpha 1,2 Fucosyltransferase Concordantly Inhibit Xenoreactivity of NIH 3T3 Cells with Human Serum

Expression of Human Alpha-Galactosidase Leads to Reduction of Major Xenoepitope Gal Alpha(1,3) Gal in Nih 3t3 Cell

Biochemical characterization and cytotoxicity of polylactosamine-extended N-glycans binding isolectins from the mushroom Hericium erinaceus

Preliminary Study on the Leukemia Targeting by a CD19 Antibody Conjugated with Saline Extracts from Mylabris Phalerata Pallas.

STUDY OF ANTI-CD9 AND CD 10 IMMUNOTOXINS KILLING LEUKEMIC CELLS AND THE EFFECT ON HEMATOPOIESIS

[Purification of Fusion Protein HSA/IL1ra and Its Bioactivity].

Comparison of the Phytohaemagglutinin from Red Kidney Bean (phaseolus Vulgaris) Purified by Different Affinity Chromatography

Study of the Killing Effect of Fetal Spleen LAK Cells on Different T-Lymphoid Leukemic Cells

Study on the Preparation of the Immunotoxin 2E8-NCTD and Its Targeting Killing Effect in Vitro.

Design of Common Bean Lectin Inhibitor and Its Hemagglutination Activity

Functional Component Isolated from Phaseolus vulgaris Lectin Exerts In Vitro and In Vivo Anti-Tumor Activity through Potentiation of Apoptosis and Immunomodulation

Cytotoxicity induced by Erythrina variegata serine proteinase inhibitors in tumor hematopoietic stem cell lines

Purification, Characterization and in Vitro Anti-Tumor Activity of Proteins from Arca Subcrenata Lischke

A Novel Lectin with Antiproliferative and HIV-1 Reverse Transcriptase Inhibitory Activities from Dried Fruiting Bodies of the Monkey Head Mushroom Hericium Erinaceum

Trypsin Isoinhibitors with Antiproliferative Activity toward Leukemia Cells from Phaseolus vulgaris cv “White Cloud Bean”

Purification and Immunochemical Studies of the Protein-Bound J Substance from Cattle Serum

Isolation and characterization of a novel lectin from the mushroom Armillaria luteo-virens.

A Quantitative Human Red Blood Cell Agglutination Assay for Characterisation of Galectin Inhibitors

Mab L9e10 To Blood Group H2 Antigen Binds To Colon Cancer Stem Cells And Inhibits Tumor Cell Migration And Invasion

Study on Inhibition Effects of Lycopene Crystals on Ectogenetic Tumor Cells